His achievements include elucidation of the structure of the T cell antigen receptor, elucidation of the function of CTLA-4, and the development of a CTLA-4–blocking antibody, which led to the development of therapeutic CTLA-4 antibodies (ipilimumab) that are now used to treat advanced melanoma.